Table 1. Clinical/pathological characteristics of patient samples.
Age | Margins | Gleason sum | Gleason primary | Gleason secondary | Gleason tertiary | Pstage |
---|---|---|---|---|---|---|
39 | Negative | 7 | 4 | 3 | T3AN0MX | |
52 | Negative | 6 | 3 | 3 | T2N0MX | |
54 | Positive | 7 | 4 | 3 | 5 | T3AN0MX |
54 | Negative | 6 | 3 | 3 | T2N0MX | |
55 | Negative | 7 | 3 | 4 | T3BN0MX | |
56 | Negative | 9 | 4 | 5 | 3 | T2N0MX |
56 | Negative | 7 | 3 | 4 | T3AN0MX | |
57 | Positive | 6 | 3 | 3 | T3AN0MX | |
57 | Positive | 7 | 3 | 4 | T3AN0MX | |
58 | Negative | 7 | 4 | 3 | 5 | T3BN0MX |
58 | Positive | 7 | 3 | 4 | T3AN0MX | |
58 | Negative | 7 | 4 | 3 | T3BN0MX | |
59 | Negative | 7 | 3 | 4 | T3BN0MX | |
60 | Negative | 7 | 3 | 4 | T3AN0MX | |
61 | Negative | 7 | 4 | 3 | 5 | T3AN0MX |
61 | Negative | 7 | 3 | 4 | T2N0MX | |
62 | Negative | 7 | 3 | 4 | 5 | T3AN0MX |
62 | Positive | 8 | 4 | 4 | 5 | T3AN0MX |
63 | Positive | 7 | 3 | 4 | T3AN0MX | |
65 | Negative | 7 | 3 | 4 | T2N0MX | |
65 | Negative | 7 | 3 | 4 | 5 | T3AN0MX |
These are data from the radical prostatectomy specimens. PStage indicates pathological stage (AJCC/UICC, seventh edition) at radical prostatectomy. There were 18 Caucasian and 2 African-American patients.